Since CBD has been shown to inhibit the enhancement of INaR caused by the Nav1.6 epilepsy mutation N1768D without disturbing the INaT density [45], we predicted that CBD would also selectively inhibit INaR and/or INaP over INaT in HEK cells stably expressing WT Nav1.2. The gene discussed is SCN2A; the disease is epilepsy.